These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3714913)

  • 1. Adrenocortical function and suicidal behavior in depressive disorders.
    Brown RP; Mason B; Stoll P; Brizer D; Kocsis J; Stokes PE; Mann JJ
    Psychiatry Res; 1986 Apr; 17(4):317-23. PubMed ID: 3714913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables.
    Brown RP; Stoll PM; Stokes PE; Frances A; Sweeney J; Kocsis JH; Mann JJ
    Psychiatry Res; 1988 Feb; 23(2):167-78. PubMed ID: 3363026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test and completed suicide.
    Norman WH; Brown WA; Miller IW; Keitner GI; Overholser JC
    Acta Psychiatr Scand; 1990 Feb; 81(2):120-5. PubMed ID: 2327273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in suicidal patients with unipolar depression.
    Targum SD; Rosen L; Capodanno AE
    Am J Psychiatry; 1983 Jul; 140(7):877-9. PubMed ID: 6859303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the adrenal cortex in patients with major depression.
    Kalin NH; Dawson G; Tariot P; Shelton S; Barksdale C; Weiler S; Thienemann M
    Psychiatry Res; 1987 Oct; 22(2):117-25. PubMed ID: 2825229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemistry and suicidal behavior in depressed patients.
    Secunda SK; Cross CK; Koslow S; Katz MM; Kocsis J; Maas JW; Landis H
    Biol Psychiatry; 1986 Jul; 21(8-9):756-67. PubMed ID: 3730460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide.
    Jokinen J; Nordström AL; Nordström P
    J Affect Disord; 2008 Feb; 106(1-2):145-52. PubMed ID: 17662471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and suicide prediction.
    Coryell W; Schlesser M
    Am J Psychiatry; 2001 May; 158(5):748-53. PubMed ID: 11329397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression.
    Yerevanian BI; Feusner JD; Koek RJ; Mintz J
    J Affect Disord; 2004 Dec; 83(2-3):103-8. PubMed ID: 15555702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J; Van Wettere JP; Depauw Y; Charles G
    Acta Psychiatr Belg; 1986; 86(3):242-8. PubMed ID: 3751647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The biological basis of suicidal behavior: neuroendocrine and psychophysiological approach to the role of catecholamines].
    Pitchot W; Hansenne M; Gonzalez Moreno A; Wauthy J; Ansseau M
    Acta Psychiatr Belg; 1995; 95(4-5):210-33. PubMed ID: 8525861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test (DST) in relation to depressive somatic and suicidal manifestations.
    Modestin J; Ruef C
    Acta Psychiatr Scand; 1987 May; 75(5):491-4. PubMed ID: 3604733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and suicide attempts in schizophrenic patients.
    Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK
    Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
    Cameron OG; Kronfol Z; Greden JF; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1090-5. PubMed ID: 6497572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
    Casper RC; Swann AC; Stokes PE; Chang S; Katz MM; Garver D
    Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory evaluation for Cushing's syndrome in psychiatric patients with cortisol nonsuppression following the overnight dexamethasone suppression test.
    Lampe TH; Fariss BL; Risse SC; Raskind MA; Plymate SR
    Biol Psychiatry; 1987 Oct; 22(10):1264-70. PubMed ID: 3663778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.